Carol B. Lindsley
Carol B. Lindsley has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Jordan T. Jones
Department of Pediatrics, Children’s Mercy Kansas City, Kansas City, USA
1 shared publication Kimberly A. Morishita
The University of British Columbia
1 shared publication- Michael A. Rapoff
University of Kansas Medical Center
1 shared publication - Randy Quentin Cron
University of Alabama at Birmingham, Birmingham, AL, USA
1 shared publication - Ross E. Petty
The University of British Columbia
1 shared publication - Sangeeta Sule
Children's National Hospital Washington DC
1 shared publication
Latest Publications
- 31 March 2023
- Published by Springer Nature
- p. 43-53
Juvenile Idiopathic Arthritis
- Open Access
- 2 February 2012
- Published by Springer Nature in Pediatric Rheumatology
- Vol. 10 (1) , 5
Policy challenges for the pediatric rheumatology workforce
- 2 February 2012
- Published by Springer Nature in Pediatric Rheumatology
- Vol. 10 (1) , 5
Open AccessPolicy challenges for the pediatric rheumatology workforce
- Open Access
- 18 May 2007
- Published by Springer Nature in Pediatric Rheumatology
- Vol. 5 (1) , 10
Improving adherence to medical regimens for juvenile rheumatoid arthritis
Poor adherence to medical regimens can compromise the efficacy of treatments for children and adolescents with juvenile rheumatoid arthritis (JRA). The purpose of this review is to describe medical regimens for the treatment of JRA and the rates of adherence to these regimens. We also summarize and critically the few research studies aimed at improving adherence to regimens for JRA. Finally, we summarize strategies for enhancing adherence in clinical practice.
- 18 May 2007
- Published by Springer Nature in Pediatric Rheumatology
- Vol. 5 (1) , 10
Open AccessImproving adherence to medical regimens for juvenile rheumatoid arthritis
Poor adherence to medical regimens can compromise the efficacy of treatments for children and adolescents with juvenile rheumatoid arthritis (JRA). The purpose of this review is to describe medical regimens for the treatment of JRA and the rates of adherence to these regimens. We also summarize and critically the few research studies aimed at improving adherence to regimens for JRA. Finally, we summarize strategies for enhancing adherence in clinical practice.
- 1 June 2006
- Published by Springer Nature in Current Rheumatology Reports
- Vol. 8 (3) , 174-177
Juvenile dermatomyositis update
Recent studies involving juvenile dermatomyositis indicate that the majority of affected children have symptoms suggestive of infection prior to disease onset, damage to skin and muscle each have a distinct pathophysiology, certain urinary muscle metabolites may be useful laboratory markers, and methotrexate used as first line therapy with corticosteroids is associated with greater height velocity and smaller increase in body mass index.
- 1 June 2006
- Published by Springer Nature in Current Rheumatology Reports
- Vol. 8 (3) , 174-177
Juvenile dermatomyositis update
Recent studies involving juvenile dermatomyositis indicate that the majority of affected children have symptoms suggestive of infection prior to disease onset, damage to skin and muscle each have a distinct pathophysiology, certain urinary muscle metabolites may be useful laboratory markers, and methotrexate used as first line therapy with corticosteroids is associated with greater height velocity and smaller increase in body mass index.